Peter Attia· MD
so you know we'll talk about incidents but we're going to talk about mortality and at the end of the day just five cancers account for half a little over half of all cancer death in the United States
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
so you know we'll talk about incidents but we're going to talk about mortality and at the end of the day just five cancers account for half a little over half of all cancer death in the United States
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
for men uh it's it's lung prostate colon pancreas
let's start at the top it's lung it's then breast and prostate in men and women it's coloral it's pancreas those are the big five they kill more than 50% of Americans it cancer wise not sorry let me restate that more than 50% of cancer deaths in Americans come from those five
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.